20
Views
16
CrossRef citations to date
0
Altmetric
Review

Recent advances in the diagnosis of Lyme disease

Pages 413-427 | Published online: 09 Jan 2014

References

  • Steere AC. Lyme disease. N. Engl. J. Med. 345, 115–125 (2001).
  • •• Good recent clinical overview on Lyme borreliosis.
  • Wang G, van Dam AP, Schwartz I, Dankert J. Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological and clinical implications. Clin. Microbiol. Rev. 12, 633–653 (1999).
  • •• Overview on taxonomy, epidemiology and clinical value of different B.burgdorferi sensu lato species.
  • Fraser CM, Casjens S, Huang WM et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390, 580–586 (1997).
  • Philipp MT, Johnson BJ. Animal models of Lyme disease: pathogenesis and immunoprophylaxis. Trends Microbiol. 2, 431–437 (1994).
  • Malawista SE, Barthold SW, Persing DH. Fate of Borrelia burgdorferi DNA in tissues of infected mice after antibiotic treatment. J. Infect. Dis. 170, 1312–1316 (1994).
  • Pahl A, Kuhlbrandt U, Brune K, Rollinghoff M, Gessner A. Quantitative detection of Borrelia burgdorferi by real-time PCR. J. Clin. Microbiol. 37, 1958–1963 (1999).
  • Straubinger RK, Summers BA, Chang YF, Appel MJG. Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. J. Clin. Microbiol. 35, 111–116 (1997).
  • Straubinger RK. PCR-Based quantification of Borrelia burgdorferi organisms in canine tissues over a 500- Day postinfection period. J. Clin. Microbiol. 38, 2191–2199 (2000).
  • Pachner AR, Zhang WF, Schaefer H, Schaefer S, ONeill T. Detection of active infection in nonhuman primates with Lyme neuroborreliosis: comparison of PCR, culture and a bioassay. J. Clin. Microbiol. 36, 3243–3247 (1998).
  • Hu CM, Wilske B, Fingerle V, Lobet Y, Gern L. Transmission of Borrelia garinii OspA serotype 4 to BALB/c mice by Ixodes ricinus ticks collected in the field. J. Clin. Microbiol. 39, 1169–1171 (2001).
  • Malovr Y, Skoberne M, Gruntar I, Kotnik V. The cell-mediated immune response to Borrelia afzelii, B. garinii and B. burgdorferi in C57BL/6 mice is dependent on antigen specificity. FEMS Immunol. Med. Microbiol. 28, 233–240 (2000).
  • American College of Physicians. Guidelines for laboratory evaluation in the diagnosis of Lyme disease. Ann. Intern. Med. 127, 1106–1108 (1997).
  • Nichol G, Dennis DT, Steere AC et al. Test-treatment strategies for patients suspected of having Lyme disease: a costeffectiveness analysis. Ann. Intern. Med. 128, 37–48 (1998).
  • Pollack RJ, Telford SR 3rd, Spielman A. Standardization of medium for culturing Lyme disease spirochetes. J. Clin. Microbiol. 31 1251–1255 (1993).
  • Preac-Mursic V, Wilske B, Schierz G. European Borrelia burgdorferi isolated from humans and ticks culture conditions and antibiotic susceptibility. Zentralbl. Bakteriol Mikrobiol. Hyg [A] 263, 112–118 (1986).
  • Kuiper H, Cairo I, Van Dam A et al. Solitary erythema migrans: a clinical, laboratory and epidemiological study of 77 Dutch patients. Br. J. Dermatol. 130, 466–472 (1994).
  • Schwartz I, Wormser GP, Schwartz JJ et al. Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions. J. Clin. Microbiol. 30, 3082–3088 (1992).
  • van Dam AP, Kuiper H, Vos K et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin. Infect. Dis. 17, 708–717 (1993).
  • Kuiper H, van Dam AP, Spanjaard L et al. Isolation of Borrelia burgdorferi from biopsy specimens taken from healthy-looking skin of patients with Lyme borreliosis. J. Clin. Microbiol. 32, 715–720 (1994).
  • Wormser GP, Nowakowski J, Nadelman RB, Bittker S, Cooper D, Pavia C. Improving the yield of blood cultures for patients with early Lyme disease. J. Clin. Microbiol. 36, 296–298 (1998).
  • Maraspin V, Ruzic-Sabljic E, Cimperman J et al. Isolation of Borrelia burgdorferi sensu lato from blood of patients with erythema migrans. Infection 29, 65–70 (2001).
  • Karlsson M, Hovind-Hougen K, Svenungsson B, Stiernstedt G. Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis. J. Clin. Microbiol. 28, 473–479 (1990).
  • Schmidt BL. PCR in laboratory diagnosis of human Borrelia burgdorferi infections. Clin. Microbiol. Rev. 10, 185–201 (1997).
  • • Overview on PCR diagnosis of Lyme borreliosis.
  • Wienecke R, Neubert U, Volkenandt M. Molecular detection of Borrelia burgdorferi in formalin-fixed, paraffin-embedded lesions of Lyme disease. J. Cutan. Pathol. 20, 385–388 (1993).
  • Wienecke R, Schlupen EM, Zochling N, Neubert U, Meurer M, Volkenandt M. No evidence for Borrelia burgdorferi-specific DNA in lesions of localized scleroderma. J. Invest. Dermatol. 104, 23–26 (1995).
  • von Stedingk LV, Olsson I, Hanson HS, Asbrink E, Hovmark A. Polymerase chain reaction for detection of Borrelia burgdorferi DNA in skin lesions of early and late Lyme borreliosis. Eur. J. Clin. Microbiol. Infect. Dis. 14, 1–5 (1995).
  • Moter SE, Hofmann H, Wallich R, Simon MM, Kramer MD. Detection of Borrelia burgdorferi sensu lato in lesional skin of patients with erythema migrans and acrodermatitis chronica atrophicans by ospA-specific PCR. J. Clin. Microbiol. 32, 2980–2988 (1994).
  • Lebech AM, Hansen K, Brandrup F, Clemmensen O, Halkier-Sorensen L. Diagnostic value of PCR for detection of Borrelia burgdorferi DNA in clinical specimens from patients with erythema migrans and Lyme neuroborreliosis. Mol. Diagn. 5, 139–150 (2000).
  • Jaulhac B, Heller R, Limbach FX et al. Direct molecular typing of Borrelia burgdorferi sensu lato species in synovial samples from patients with lyme arthritis. J. Clin. Microbiol. 38, 1895–1900 (2000).
  • Picken MM, Picken RN, Han D et al. A two year prospective study to compare culture and polymerase chain reaction amplification for the detection and diagnosis of Lyme borreliosis. Mol. Pathol. 50, 186–193 (1997).
  • Brettschneider S, Bruckbauer H, Klugbauer N, Hofmann H. Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis. J. Clin. Microbiol. 36, 2658–2665 (1998).
  • Steere AC, Sikand VK, Meurice F et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outersurface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N. Engl. J. Med. 339, 209–215 (1998).
  • •• Study designed to evaluate a vaccine but the placebo group is an excellent prospective study on the incidence and diagnosis of Lyme disease.
  • Lebech AM, Hansen K. Detection of Borrelia burgdorferi DNA in urine samples and cerebrospinal fluid samples from patients with early and late Lyme neuroborreliosis by polymerase chain reaction. J. Clin. Microbiol. 30, 1646–1653 (1992).
  • Zbinden R, Goldenberger D, Lucchini GM, Altwegg M. Comparison of two methods for detecting it. synthesis of Borrelia burgdorferi-specific antibodies and PCR for diagnosis of Lyme neuroborreliosis. J. Clin. Microbiol. 32, 1795–1798 (1994).
  • Luft BJ, Steinman CR, Neimark HC et al. Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection. JAMA 267, 1364–1367 (1992).
  • Pachner AR, Delaney E. The polymerase chain reaction in the diagnosis of Lyme neuroborreliosis. Ann. Neurol. 34, 544–550 (1993).
  • Liebling MR, Nishio MJ, Rodriguez A, Sigal LH, Jin T, Louie JS. The polymerase chain reaction for the detection of Borrelia burgdorferi in human body fluids. Arthritis Rheum. 36, 665–675 (1993).
  • Debue M, Gautier P, Hackel C et al. Detection of Borrelia burgdorferi in biological samples using the polymerase chain reaction assay. Res. Microbiol. 142, 565–572 (1991).
  • Keller TL, Halperin JJ, Whitman M. PCR detection of Borrelia burgdorferi DNA in cerebrospinal fluid of Lyme neuroborreliosis patients. Neurology 42, 32–42 (1992).
  • Eiffert H, Ohlenbusch A, Christen HJ, Thomssen R, Spielman A, Matuschka FR. Nondifferentiation between Lyme disease spirochetes from vector ticks and human cerebrospinal fluid. J. Infect. Dis. 171, 476–479 (1995).
  • Huppertz HI, Schmidt H, Karch H. Detection of Borrelia burgdorferi by nested polymerase chain reaction in cerebrospinal fluid and urine of children with neuroborreliosis. Eur. J. Pediatr. 152, 414–417 (1993).
  • Amouriaux P, Assous M, Margarita D, Baranton G, Saint Girons I. Polymerase chain reaction with the 30–kb circular plasmid of Borrelia burgdorferi B31 as a target for detection of the Lyme borreliosis agents in cerebrospinal fluid. Res. Microbiol. 144, 211–219 (1993).
  • Priem S, Rittig MG, Kamradt T, Burmester GR, Krause A. An optimized PCR leads to rapid and highly sensitive detection of Borrelia burgdorferi in patients with Lyme borreliosis. J. Clin. Microbiol. 35, 685–690 (1997).
  • Nocton JJ, Bloom BJ, Rutledge BJ et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis. J. Infect. Dis. 174, 623–627 (1996).
  • Nocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH, Steere AC. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N. Engl. J. Med. 330, 229–234 (1994).
  • • Very large study on the diagnostic value of PCR in Lyme arthritis, including good clinical data.
  • Jaulhac B, Chary-Valckenaere I, Sibilia J et al. Detection of Borrelia burgdorferi by DNA amplification in synovial tissue samples from patients with Lyme arthritis. Arthritis Rheum. 39, 736–745 (1996).
  • Persing DH, Rutledge BJ, Rys PN et al. Target imbalance: disparity of Borrelia burgdorferi genetic material in synovial fluid from Lyme arthritis patients. J. Infect. Dis. 169, 668–672 (1994).
  • Goodman JL, Bradley JF, Ross AE et al. Bloodstream invasion in early Lyme disease: results from a prospective, controlled, blinded study using the polymerase chain reaction. Am. J. Med. 99, 6–12 (1995).
  • Demaerschalck I, Messaoud BA, De Kesel M et al. Simultaneous presence of different Borrelia burgdorferi genospecies in biological fluids of Lyme disease patients. J. Clin. Microbiol. 33, 602–608 (1995).
  • Mouritsen CL, Wittwer CT, Litwin CM et al. Polymerase chain reaction detection of Lyme disease: correlation with clinical manifestations and serologic responses. Am. J. Clin. Pathol. 105, 647–654 (1996).
  • Schmidt B, Muellegger RR, Stockenhuber C et al. Detection of Borrelia burgdorferispecific DNA in urine specimens from patients with erythema migrans before and after antibiotic therapy. J. Clin. Microbiol. 34, 1359–1363 (1996).
  • Maiwald M, Stockinger C, Hassler D, von Knebel Doeberitz M, Sonntag HG. Evaluation of the detection of Borrelia burgdorferi DNA in urine samples by polymerase chain reaction. Infection 23, 173–179 (1995).
  • Pleyer U, Priem S, Bergmann L, Burmester G, Hartmann C, Krause A. Detection of Borrelia burgdorferi DNA in urine of patients with ocular Lyme borreliosis. Br. J. Ophthalmol. 85, 552–555 (2001).
  • Karch H, Huppertz HI, Bohme M, Schmidt H, Wiebecke D, Schwarzkopf A. Demonstration of Borrelia burgdorferi DNA in urine samples from healthy humans whose sera contain B. burgdorferispecific antibodies. J. Clin. Microbiol. 32, 2312–2314 (1994).
  • Muellegger R, Zoechling N, Schluepen EM et al. Polymerase chain reaction control of antibiotic treatment in dermatoborreliosis. Infection 24, 76–79 (1996).
  • Gross DM, Forsthuber T, Tary-Lehmann M et al. Identification of LFA-1 as a candidate autoantigen in treatmentresistant Lyme arthritis. Science 281, 703–706 (1998).
  • Priem S, Burmester GR, Kamradt T, Wolbart K, Rittig MG, Krause A. Detection of Borrelia burgdorferi by polymerase chain reaction in synovial membrane but not in synovial fluid from patients with persisting Lyme arthritis after antibiotic therapy. Ann. Rheum. Dis. 57, 118–121 (1998).
  • Carlson D, Hernandez J, Bloom BJ, Coburn J, Aversa JM, Steere AC. Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum. 42, 2705–2709 (1999).
  • Oksi J, Marjamaki M, Nikoskelainen J, Viljanen MK. Borrelia burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis. Ann. Med. 31, 225–232 (1999).
  • Bayer ME, Zhang L, Bayer MH. Borrelia burgdorferi DNA in the urine of treated patients with chronic Lyme disease symptoms. A PCR study of 97 cases. Infection 24, 347–353 (1996).
  • Busch U, Hizo-Teufel C, Boehmer R et al. Three species of Borrelia burgdorferi sensu lato (B. burgdorferi sensu stricto, B. afzelii and B. garinii) identified from cerebrospinal fluid isolates by pulsed-field gel electrophoresis and PCR. J. Clin. Microbiol. 34, 1072–1078 (1996).
  • Wormser GP, Liveris D, Nowakowski J et al. Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease. J. Infect. Dis. 180, 720–725 (1999).
  • Morrison TB, Ma Y, Weis JH, Weis JJ. Rapid and sensitive quantification of Borrelia burgdorferi-infected mouse tissues by continuous fluorescent monitoring of PCR. J. Clin. Microbiol. 37, 987–92 (1999).
  • Mommert S, Gutzmer R, Kapp A, Werfel T. Senstive detection of Borrelia burgdorferi sensu lato DNA and differentiation of Borrelia species by Light Cycler PCR. J. Clin. Microbiol. 39, 2663–2667 (2001).
  • Schwaiger M, Peter O, Cassinotti P. Routine diagnosis of Borrelia burgdorferi (sensu lato) infections using a real-time PCR assay. Clin. Microbiol. Infect. 7, 461–469 (2001).
  • Nowakowski J, Schwartz I, Liveris D et al. Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques. Clin. Infect. Dis. 33, 2023–2027 (2001).
  • Aguero-Rosenfeld ME, Nowakowski J, McKenna DF, Carbonaro CA, Wormser GP. Serodiagnosis in early Lyme disease. J. Clin. Microbiol. 31, 3090–3095 (1993).
  • Padula SJ, Dias F, Sampieri A, Craven RB, Ryan RW. Use of recombinant OspC from Borrelia burgdorferi for serodiagnosis of early Lyme disease. J. Clin. Microbiol. 32, 1733–1738 (1994).
  • Hansen K, Pii K, Lebech AM. Improved immunoglobulin M serodiagnosis in Lyme borreliosis by using a -capture enzymelinked immunosprbent assay with biotinylated Borrelia burgdorferi flagellin. J. Clin. Microbiol. 29, 166–173 (1991).
  • Hauser U, Krahl H, Peters H, Fingerle V, Wilske B. Impact of strain heterogeneity on Lyme disease serology in Europe: comparison of enzyme-linked immunosorbent assays using different species of Borrelia burgdorferi sensu lato. J. Clin. Microbiol. 36, 427–436 (1998).
  • Dressler F, Whalen JA, Reinhardt BN, Steere AC. Western blotting in the serodiagnosis of Lyme disease. J. Infect. Dis. 167, 392–400 (1993).
  • • Describes standardized criteria for interpretation of Western blots in North American patients.
  • Oksi J, Uksila J, Marjamaki M, Nikoskelainen J, Viljanen MK. Antibodies against whole sonicated Borrelia burgdorferi spirochetes, 41-kilodalton flagellin and P39 protein in patients with PCR- or cultureproven late Lyme borreliosis. J. Clin. Microbiol. 33, 2260–2264 (1995).
  • Engstrom SM, Shoop E, Johnson RC. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J. Clin. Microbiol. 33, 419–427 (1995).
  • Sivak SL, Aguero-Rosenfeld ME, Nowakowski J, Nadelman RB, Wormser GP. Accuracy of IgM immunoblotting to confirm the clinical diagnosis of early Lyme disease. Arch. Intern. Med. 156, 2105–2109 (1996).
  • Hauser U, Lehnert G, Lobentanzer R, Wilske B. Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato. J. Clin. Microbiol. 35, 1433–1444 (1997).
  • •• Standardized criteria for interpretation of Western blots in European patients, including comparison of various strains as antigens.
  • Robertson J, Guy E, Andrews N et al. A European multicenter study of immunoblotting in serodiagnosis of Lyme borreliosis. J. Clin. Microbiol. 38, 2097–2102 (2000).
  • Johnson BJB, Robbins KE, Bailey RE et al. Serodiagnosis of Lyme disease: accuracy of a two-step approach using a flagellin-based ELISA and immunoblotting. J. Infect. Dis. 174, 346–353 (1996).
  • Ledue TB, Collins MF, Craig WY. New laboratory guidelines for serologic diagnosis of Lyme disease: evaluation of the two-test protocol. J. Clin. Microbiol. 34, 2343–2350 (1996).
  • Trevejo RT, Krause PJ, Sikand VK et al. Evaluation of two-test serodiagnostic method for early Lyme disease in clinical practice. J. Infect. Dis. 179, 931–938 (1999).
  • Hansen K, Lebech AM. Lyme neuroborreliosis: a new sensitive diagnostic assay for it. synthesis of Borrelia burgdorferispecific immunoglobulin G, A and M. Ann. Neurol. 30, 197–205 (1991).
  • Jespersen D, Jones M, Wold A, Rosenblatt J, Smith T, Cockerill F. Comparison of three serologic assays for Lyme disease testing. Abstract, 40th ICAAC (2000).
  • Fung BP, McHugh GL, Leong JM, Steere AC. Humoral immune response to outer surface protein C of Borrelia burgdorferi in Lyme disease: role of the immunoglobulin M response in serodiagnosis of early infection. Infect. Immun. 62, 3213–3221 (1994).
  • Rauer S, Spohn N, Rasiah C, Neubert U, Vogt A. Enzyme-linked immunosorbent assay using recombinant OspC and the internal 14-kDa flagellin fragment for serodiagnosis of early Lyme disease. J. Clin. Microbiol. 36, 857–861 (1998).
  • Kaiser R, Rauer S. Advantage of recombinant borrelial proteins for serodiagnosis of neuroborreliosis. J. Med. Microbiol. 48, 5–10 (1999).
  • Fikrig E, Barthold SW, Sun W, Feng W, Telford SR 3rd, Flavell RA. Borrelia burgdorferi P35 and P37 proteins, expressed in vivo, elicit protective immunity. Immunity 6, 531–539 (1997).
  • Akin E, McHugh GL, Flavell RA, Fikrig E, Steere AC. The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect. Immun. 67, 173–181 (1999).
  • LawrenzMB, Hardham JM, Owens RT et al. Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J. Clin. Microbiol. 37, 3997–4004 (1999).
  • Liang FT, Steere AC, Marques AR, Johnson BJ, Miller JN, Philipp MT. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE. J. Clin. Microbiol. 37, 3990–3996 (1999).
  • Philipp MT, Bowers LC, Fawcett PT et al. Antibody Response to IR6, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans. J. Infect. Dis. 184, 870–878 (2001).
  • Gilmore RD Jr, Kappel KJ, Johnson BJ. Molecular characterization of a 35- kilodalton protein of Borrelia burgdorferi, an antigen of diagnostic importance in early Lyme disease. J. Clin. Microbiol. 35, 86–91 (1997).
  • Gilmore RD Jr, Murphree RL, James AM, Sullivan SA, Johnson BJ. The Borrelia burgdorferi 37-kilodalton immunoblot band (P37) used in serodiagnosis of early lyme disease is the flaA gene product. J. Clin. Microbiol. 37, 548–552 (1999).
  • Gomes-Solecki MJ, Dunn JJ, Luft BJ et al. Recombinant chimeric Borrelia proteins for diagnosis of Lyme disease. J. Clin. Microbiol. 38 2530–2535 (2000).
  • Gomes-Solecki MJ, Wormser GP, Persing DH et al. A first-tier rapid assay for the serodiagnosis of Borrelia burgdorferi infection. Arch. Intern. Med. 161, 2015–2020 (2001).
  • Wilske B, Fingerle V, Herzer P et al. Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay. Med. Microbiol. Immunol. (Berl) 182, 255–70 (1993).
  • Wilske B, Habermann C, Fingerle V et al. An improved recombinant IgG immunoblot for serodiagnosis of Lyme borreliosis. Med. Microbiol. Immunol. (Berl) 188, 139–144 (1999).
  • Fawcett PT, Rose CR, Gibney KM, Doughty RA. Comparison of immunodot and Western blot assays for diagnosing Lyme borreliosis. Clin. Diagn. Lab. Immunol. 5, 503–506 (1998).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.